{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T12:19:44Z","timestamp":1794745184083,"version":"4.9.1"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T00:00:00Z","timestamp":1745193600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T00:00:00Z","timestamp":1745193600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-59093-7","type":"journal-article","created":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T14:56:02Z","timestamp":1745247362000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":67,"title":["Targeted immunotherapy rescues pulmonary fibrosis by reducing activated fibroblasts and regulating alveolar cell profile"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3671-7399","authenticated-orcid":false,"given":"Jing","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6484-8153","authenticated-orcid":false,"given":"Song-Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2765-0458","authenticated-orcid":false,"given":"Qi","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5127-5999","authenticated-orcid":false,"given":"Min-Wen","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4488-4744","authenticated-orcid":false,"given":"Zi-Yue","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Shou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4121-3224","authenticated-orcid":false,"given":"Yunlong","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,21]]},"reference":[{"key":"59093_CR1","doi-asserted-by":"publisher","first-page":"276","DOI":"10.15252\/emmm.201606261","volume":"10","author":"HM Al-Tamari","year":"2018","unstructured":"Al-Tamari, H. M. et al. FoxO3 an important player in fibrogenesis and therapeutic target for idiopathic pulmonary fibrosis. EMBO Mol. Med. 10, 276\u2013293 (2018).","journal-title":"EMBO Mol. Med"},{"key":"59093_CR2","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/resp.12683","volume":"21","author":"G Sgalla","year":"2016","unstructured":"Sgalla, G., Biffi, A. & Richeldi, L. Idiopathic pulmonary fibrosis: Diagnosis, epidemiology and natural history. Respirology 21, 427\u2013437 (2016).","journal-title":"Respirology"},{"key":"59093_CR3","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1146\/annurev-pathol-012513-104706","volume":"9","author":"PJ Wolters","year":"2014","unstructured":"Wolters, P. J., Collard, H. R. & Jones, K. D. Pathogenesis of idiopathic pulmonary fibrosis. Annu Rev. Pathol. 9, 157\u2013179 (2014).","journal-title":"Annu Rev. Pathol."},{"key":"59093_CR4","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1016\/S0140-6736(17)30866-8","volume":"389","author":"L Richeldi","year":"2017","unstructured":"Richeldi, L., Collard, H. R. & Jones, M. G. Idiopathic pulmonary fibrosis. Lancet 389, 1941\u20131952 (2017).","journal-title":"Lancet"},{"key":"59093_CR5","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1093\/qjmed\/hcac206","volume":"116","author":"T Parimon","year":"2013","unstructured":"Parimon, T. et al. Potential mechanisms for lung fibrosis associated with COVID-19 infection. QJM 116, 487\u2013492 (2013).","journal-title":"QJM"},{"key":"59093_CR6","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.mam.2018.08.004","volume":"65","author":"D Chanda","year":"2019","unstructured":"Chanda, D. et al. Developmental pathways in the pathogenesis of lung fibrosis. Mol. Asp. Med. 65, 56\u201369 (2019).","journal-title":"Mol. Asp. Med"},{"key":"59093_CR7","doi-asserted-by":"publisher","first-page":"14959","DOI":"10.3390\/ijms232314959","volume":"23","author":"IA Savin","year":"2022","unstructured":"Savin, I. A., Zenkova, M. A. & Sen\u2019kova, A. V. Pulmonary fibrosis as a result of acute lung inflammation: molecular mechanisms, relevant in vivo models, prognostic and therapeutic approaches. Int J. Mol. Sci. 23, 14959 (2022).","journal-title":"Int J. Mol. Sci."},{"key":"59093_CR8","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/s41586-020-2938-9","volume":"587","author":"NC Henderson","year":"2020","unstructured":"Henderson, N. C., Rieder, F. & Wynn, T. A. Fibrosis: from mechanisms to medicines. Nature 587, 555\u2013566 (2020).","journal-title":"Nature"},{"key":"59093_CR9","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41586-019-1546-z","volume":"573","author":"H Aghajanian","year":"2019","unstructured":"Aghajanian, H. et al. Targeting cardiac fibrosis with engineered T cells. Nature 573, 430\u2013433 (2019).","journal-title":"Nature"},{"key":"59093_CR10","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1126\/science.aay5967","volume":"367","author":"K Reinhard","year":"2020","unstructured":"Reinhard, K. et al. An RNA vaccine drives expansion and efficacy of claudin-CAR-T cells against solid tumors. Science 367, 446\u2013453 (2020).","journal-title":"Science"},{"key":"59093_CR11","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/nature18300","volume":"534","author":"LM Kranz","year":"2016","unstructured":"Kranz, L. M. et al. Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy. Nature 534, 396\u2013401 (2016).","journal-title":"Nature"},{"key":"59093_CR12","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1126\/science.abm0594","volume":"375","author":"Rurik","year":"2022","unstructured":"Rurik et al. CAR T cells produced in vivo to treat cardiac injury. Science 375, 91\u201396 (2022).","journal-title":"Science"},{"key":"59093_CR13","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/s41586-022-04541-3","volume":"604","author":"P Kadur Lakshminarasimha Murthy","year":"2022","unstructured":"Kadur Lakshminarasimha Murthy, P. et al. Human distal lung maps and lineage hierarchies reveal a bipotent progenitor. Nature 604, 111\u2013119 (2022).","journal-title":"Nature"},{"key":"59093_CR14","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nature25786","volume":"555","author":"WJ Zacharias","year":"2018","unstructured":"Zacharias, W. J. et al. Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor. Nature 555, 251\u2013255 (2018).","journal-title":"Nature"},{"key":"59093_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14527-2","volume":"11","author":"S Patel","year":"2020","unstructured":"Patel, S. et al. Naturally-occurring cholesterol analogues in lipid nanoparticles induce polymorphic shape and enhance intracellular delivery of mRNA. Nat. Commun. 11, 983 (2020).","journal-title":"Nat. Commun."},{"key":"59093_CR16","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.75660","volume":"11","author":"A Elazar","year":"2022","unstructured":"Elazar, A. et al. De novo-designed transmembrane domains tune engineered receptor functions. Elife 11, e75660 (2022).","journal-title":"Elife"},{"key":"59093_CR17","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41591-019-0737-3","volume":"26","author":"JN Brudno","year":"2020","unstructured":"Brudno, J. N. et al. Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma. Nat. Med 26, 270\u2013280 (2020).","journal-title":"Nat. Med"},{"key":"59093_CR18","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1158\/2159-8290.CD-19-0945","volume":"10","author":"RG Majzner","year":"2020","unstructured":"Majzner, R. G. et al. Tuning the antigen density requirement for CAR T-cell Activity. Cancer Discov. 10, 702\u2013723 (2020).","journal-title":"Cancer Discov."},{"key":"59093_CR19","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.ejphar.2008.06.046","volume":"590","author":"H Oku","year":"2008","unstructured":"Oku, H. et al. Antifibrotic action of pirfenidone and prednisolone: different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis. Eur. J. Pharm. 590, 400\u2013408 (2008).","journal-title":"Eur. J. Pharm."},{"key":"59093_CR20","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1165\/rcmb.2017-0096ST","volume":"56","author":"RG Jenkins","year":"2017","unstructured":"Jenkins, R. G. et al. An official american thoracic society workshop report: Use of animal models for the preclinical assessment of potential therapies for pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 56, 667\u2013679 (2017).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"59093_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.113689","volume":"43","author":"Y Mao","year":"2024","unstructured":"Mao, Y. et al. Deep spatial proteomics reveals region-specific features of severe COVID-19-related pulmonary injury. Cell Rep. 43, 113689 (2024).","journal-title":"Cell Rep."},{"key":"59093_CR22","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1038\/s41556-020-0542-8","volume":"22","author":"Y Kobayashi","year":"2020","unstructured":"Kobayashi, Y. et al. Persistence of a regeneration-associated, transitional alveolar epithelial cell state in pulmonary fibrosis. Nat. Cell Biol. 22, 934\u2013946 (2020).","journal-title":"Nat. Cell Biol."},{"key":"59093_CR23","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.cell.2019.11.027","volume":"180","author":"H Wu","year":"2020","unstructured":"Wu, H. et al. Progressive pulmonary fibrosis is caused by elevated mechanical tension on alveolar stem cells. Cell 180, 107\u2013121(2020).","journal-title":"Cell"},{"key":"59093_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.112245","volume":"145","author":"Y Yoo","year":"2022","unstructured":"Yoo, Y. et al. Therapeutic potential of targeting cathepsin S in pulmonary fibrosis. Biomed. Pharmacother. 145, 112245 (2022).","journal-title":"Biomed. Pharmacother."},{"key":"59093_CR25","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1136\/thoraxjnl-2013-204608","volume":"69","author":"D Bartis","year":"2014","unstructured":"Bartis, D., Mise, N., Mahida, R. Y., Eickelberg, O. & Thickett, D. R. Epithelial-mesenchymal transition in lung development and disease: does it exist and is it important? Thorax 69, 760\u2013765 (2014).","journal-title":"Thorax"},{"key":"59093_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.798583","volume":"13","author":"F Yuan","year":"2022","unstructured":"Yuan, F. et al. Roles of the m6A Modification of RNA in the glioblastoma microenvironment as revealed by single-cell analyses. Front Immunol. 13, 798583 (2022).","journal-title":"Front Immunol."},{"key":"59093_CR27","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/s41580-022-00465-y","volume":"23","author":"CE Buckley","year":"2022","unstructured":"Buckley, C. E. & St Johnston, D. Apical-basal polarity and the control of epithelial form and function. Nat. Rev. Mol. Cell Biol. 23, 559\u2013577 (2022).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"59093_CR28","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1038\/ncb2635","volume":"14","author":"G Apodaca","year":"2012","unstructured":"Apodaca, G., Gallo, L. I. & Bryant, D. M. Role of membrane traffic in the generation of epithelial cell asymmetry. Nat. Cell Biol. 14, 1235\u20131243 (2012).","journal-title":"Nat. Cell Biol."},{"key":"59093_CR29","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1083\/jcb.201208150","volume":"200","author":"J Hayase","year":"2013","unstructured":"Hayase, J. et al. The WD40 protein Morg1 facilitates Par6-aPKC binding to Crb3 for apical identity in epithelial cells. J. Cell Biol. 200, 635\u2013650 (2013).","journal-title":"J. Cell Biol."},{"key":"59093_CR30","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/s41586-024-07660-1","volume":"631","author":"T Tsukui","year":"2024","unstructured":"Tsukui, T., Wolters, P. J. & Sheppard, D. Alveolar fibroblast lineage orchestrates lung inflammation and fibrosis. Nature 631, 627\u2013634 (2024).","journal-title":"Nature"},{"key":"59093_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15647-5","volume":"11","author":"T Tsukui","year":"2020","unstructured":"Tsukui, T. et al. Collagen-producing lung cell atlas identifies multiple subsets with distinct localization and relevance to fibrosis. Nat. Commun. 11, 1920 (2020).","journal-title":"Nat. Commun."},{"key":"59093_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcb.2022.151242","volume":"101","author":"J Bourque","year":"2022","unstructured":"Bourque, J., Kousnetsov, R. & Hawiger, D. Roles of hopx in the differentiation and functions of immune cells. Eur. J. Cell Biol. 101, 151242 (2022).","journal-title":"Eur. J. Cell Biol."},{"key":"59093_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-53330-1","volume":"15","author":"B Kim","year":"2024","unstructured":"Kim, B. et al. PCLAF-DREAM drives alveolar cell plasticity for lung regeneration. Nat. Commun. 15, 9169 (2024).","journal-title":"Nat. Commun."},{"key":"59093_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1230266","volume":"14","author":"J Lv","year":"2023","unstructured":"Lv, J. et al. Dynamic atlas of immune cells reveals multiple functional features of macrophages associated with progression of pulmonary fibrosis. Front Immunol. 14, 1230266 (2023).","journal-title":"Front Immunol."},{"key":"59093_CR35","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abl7482","volume":"7","author":"DE Sanin","year":"2022","unstructured":"Sanin, D. E. et al. A common framework of monocyte-derived macrophage activation. Sci. Immunol. 7, eabl7482 (2022).","journal-title":"Sci. Immunol."},{"key":"59093_CR36","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/s41590-023-01479-0","volume":"24","author":"T Chavakis","year":"2023","unstructured":"Chavakis, T., Alexaki, V. I. & Ferrante, A. W. Jr Macrophage function in adipose tissue homeostasis and metabolic inflammation. Nat. Immunol. 24, 757\u2013766 (2023).","journal-title":"Nat. Immunol."},{"key":"59093_CR37","doi-asserted-by":"publisher","DOI":"10.1126\/science.abe6474","volume":"374","author":"L Zheng","year":"2021","unstructured":"Zheng, L. et al. Pan-cancer single-cell landscape of tumor-infiltrating T cells. Science 374, abe6474 (2021).","journal-title":"Science"},{"key":"59093_CR38","doi-asserted-by":"crossref","unstructured":"Younesi, F. S., Miller, A. E., Barker, T. H., Rossi, F. M. V. & Hinz, B. Fibroblast and myofibroblast activation in normal tissue repair and fibrosis. Nat. Rev. Mol. Cell Biol. 8, 617\u2013638 (2024).","DOI":"10.1038\/s41580-024-00716-0"},{"key":"59093_CR39","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abq6691","volume":"7","author":"ID Odell","year":"2022","unstructured":"Odell, I. D. et al. Epiregulin is a dendritic cell-derived EGFR ligand that maintains skin and lung fibrosis. Sci. Immunol. 7, eabq6691 (2022).","journal-title":"Sci. Immunol."},{"key":"59093_CR40","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1056\/NEJMoa1402582","volume":"370","author":"TE King Jr.","year":"2014","unstructured":"King, T. E. Jr. et al. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N. Engl. J. Med 370, 2083\u20132092 (2014).","journal-title":"N. Engl. J. Med"},{"key":"59093_CR41","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1056\/NEJMoa2201737","volume":"386","author":"L Richeldi","year":"2022","unstructured":"Richeldi, L. et al. Trial of a preferential phosphodiesterase 4B inhibitor for idiopathic pulmonary fibrosis. N. Engl. J. Med 386, 2178\u20132187 (2022).","journal-title":"N. Engl. J. Med"},{"key":"59093_CR42","first-page":"2401484","volume":"7","author":"HY Yoon","year":"2024","unstructured":"Yoon, H. Y., Kim, H., Bae, Y. & Song, J. W. Pirfenidone and risk of lung cancer development in IPF: a nationwide population-based study. Eur. Respir. J. 7, 2401484 (2024).","journal-title":"Eur. Respir. J."},{"key":"59093_CR43","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1465-9921-15-16","volume":"15","author":"M Inomata","year":"2014","unstructured":"Inomata, M. et al. Pirfenidone inhibits fibrocyte accumulation in the lungs in bleomycin-induced murine pulmonary fibrosis. Respir. Res 15, 16 (2014).","journal-title":"Respir. Res"},{"key":"59093_CR44","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1021\/acs.accounts.1c00544","volume":"55","author":"Y Eygeris","year":"2022","unstructured":"Eygeris, Y., Gupta, M., Kim, J. & Sahay, G. Chemistry of lipid nanoparticles for RNA Delivery. Acc. Chem. Res 55, 2\u201312 (2022).","journal-title":"Acc. Chem. Res"},{"key":"59093_CR45","doi-asserted-by":"crossref","unstructured":"Eygeris. Y., Patel. S., Jozic. A., Sahay. G. Deconvoluting Lipid Nanoparticle Structure for Messenger RNA Delivery. Nano Lett 20, 4543\u20134549 (2020).","DOI":"10.1021\/acs.nanolett.0c01386"},{"key":"59093_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2021.121339","volume":"281","author":"A Kheirolomoom","year":"2022","unstructured":"Kheirolomoom, A. et al. In situ T-cell transfection by anti-CD3-conjugated lipid nanoparticles leads to T-cell activation, migration, and phenotypic shift. Biomaterials 281, 121339 (2022).","journal-title":"Biomaterials"},{"key":"59093_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45422-9","volume":"15","author":"L Xue","year":"2024","unstructured":"Xue, L. et al. High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models. Nat. Commun. 15, 1884 (2024).","journal-title":"Nat. Commun."},{"key":"59093_CR48","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.jconrel.2018.10.015","volume":"291","author":"H Parhiz","year":"2018","unstructured":"Parhiz, H. et al. PECAM-1 directed re-targeting of exogenous mRNA providing two orders of magnitude enhancement of vascular delivery and expression in lungs independent of apolipoprotein E-mediated uptake. J. Control Release 291, 106\u2013115 (2018).","journal-title":"J. Control Release"},{"key":"59093_CR49","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0014-5793(99)01320-4","volume":"460","author":"T Ishida","year":"1999","unstructured":"Ishida, T., Iden, D. L. & Allen, T. M. A combinatorial approach to producing sterically stabilized (Stealth) immunoliposomal drugs. FEBS Lett. 460, 129\u2013133 (1999).","journal-title":"FEBS Lett."},{"key":"59093_CR50","first-page":"31","volume":"13","author":"D Kim","year":"2021","unstructured":"Kim, D., Wu, Y., Li, Q. & Oh, Y. K. Nanoparticle-mediated lipid metabolic reprogramming of t cells in tumor microenvironments for immunometabolic therapy. Nanomicro Lett. 13, 31 (2021).","journal-title":"Nanomicro Lett."},{"key":"59093_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17358-3","volume":"11","author":"M Strunz","year":"2020","unstructured":"Strunz, M. et al. Alveolar regeneration through a Krt8+ transitional stem cell state that persists in human lung fibrosis. Nat. Commun. 11, 3559 (2020).","journal-title":"Nat. Commun."},{"key":"59093_CR52","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/nrm3896","volume":"15","author":"JD Humphrey","year":"2014","unstructured":"Humphrey, J. D., Dufresne, E. R. & Schwartz, M. A. Mechanotransduction and extracellular matrix homeostasis. Nat. Rev. Mol. Cell Biol. 15, 802\u2013812 (2014).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"59093_CR53","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41580-019-0134-2","volume":"20","author":"JZ Kechagia","year":"2019","unstructured":"Kechagia, J. Z., Ivaska, J. & Roca-Cusachs, P. Integrins as biomechanical sensors of the microenvironment. Nat. Rev. Mol. Cell Biol. 20, 457\u2013473 (2019).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"59093_CR54","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/s41586-020-2612-2","volume":"584","author":"O Chaudhuri","year":"2020","unstructured":"Chaudhuri, O., Cooper-White, J., Janmey, P. A., Mooney, D. J. & Shenoy, V. B. Effects of extracellular matrix viscoelasticity on cellular behaviour. Nature 584, 535\u2013546 (2020).","journal-title":"Nature"},{"key":"59093_CR55","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/s41590-024-01830-z","volume":"25","author":"H Theobald","year":"2024","unstructured":"Theobald, H. et al. Apolipoprotein E controls Dectin-1-dependent development of monocyte-derived alveolar macrophages upon pulmonary \u03b2-glucan-induced inflammatory adaptation. Nat. Immunol. 25, 994\u20131006 (2024).","journal-title":"Nat. Immunol."},{"key":"59093_CR56","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.134539","volume":"5","author":"H Cui","year":"2020","unstructured":"Cui, H. et al. Monocyte-derived alveolar macrophage apolipoprotein E participates in pulmonary fibrosis resolution. JCI Insight 5, e134539 (2020).","journal-title":"JCI Insight"},{"key":"59093_CR57","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1158\/2326-6066.CIR-13-0027","volume":"2","author":"LC Wang","year":"2014","unstructured":"Wang, L. C. et al. Targeting fibroblast activation protein in tumor stroma with chimeric antigen receptor T cells can inhibit tumor growth and augment host immunity without severe toxicity. Cancer Immunol. Res 2, 154\u2013166 (2014).","journal-title":"Cancer Immunol. Res"},{"key":"59093_CR58","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1158\/2326-6066.CIR-15-0263","volume":"4","author":"K Newick","year":"2016","unstructured":"Newick, K. et al. Augmentation of CAR T-cell trafficking and antitumor efficacy by blocking protein kinase a localization. Cancer Immunol. Res 4, 541\u2013551 (2016).","journal-title":"Cancer Immunol. Res"},{"key":"59093_CR59","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/s41586-020-2622-0","volume":"586","author":"KS Corbett","year":"2020","unstructured":"Corbett, K. S. et al. SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness. Nature 586, 567\u2013571 (2020).","journal-title":"Nature"},{"key":"59093_CR60","doi-asserted-by":"publisher","unstructured":"Von. Niessen. A. G. O. Optimization of RNA Cancer Vaccines Using 3\u2019UTR Sequences Selected for Stabilization of RNA. Universit\u00e4tsbibliothek Mainz https:\/\/doi.org\/10.25358\/openscience-5189 (2016).","DOI":"10.25358\/openscience-5189"},{"key":"59093_CR61","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1261\/rna.069286.118","volume":"25","author":"Z Trepotec","year":"2019","unstructured":"Trepotec, Z., Geiger, J., Plank, C., Aneja, M. K. & Rudolph, C. Segmented poly(A) tails significantly reduce recombination of plasmid DNA without affecting mRNA translation efficiency or half-life. RNA 25, 507\u2013518 (2019).","journal-title":"RNA"},{"key":"59093_CR62","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1038\/mt.2013.124","volume":"21","author":"MA Maier","year":"2013","unstructured":"Maier, M. A. et al. Biodegradable lipids enabling rapidly eliminated lipid nanoparticles for systemic delivery of RNAi therapeutics. Mol. Ther. 21, 1570\u20131578 (2013).","journal-title":"Mol. Ther."},{"key":"59093_CR63","doi-asserted-by":"publisher","first-page":"507","DOI":"10.2144\/000112729","volume":"44","author":"H\u00fcbner","year":"2008","unstructured":"H\u00fcbner et al. Standardized quantification of pulmonary fibrosis in histological samples. Biotechniques 44, 507\u2013511 (2008).","journal-title":"Biotechniques"},{"key":"59093_CR64","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1136\/jcp.41.4.467","volume":"41","author":"T Ashcroft","year":"1988","unstructured":"Ashcroft, T., Simpson, J. M. & Timbrell, V. Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J. Clin. Pathol. 41, 467\u2013470 (1988).","journal-title":"J. Clin. Pathol."},{"key":"59093_CR65","unstructured":"Yan, J. https:\/\/BioRender.com\/c53i130 (2025)."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59093-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59093-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59093-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T16:01:10Z","timestamp":1745251270000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59093-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,21]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["59093"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-59093-7","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,21]]},"assertion":[{"value":"10 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3748"}}